All News

The Everlywell COVID-19 Test Home Collection Kit is the only authorized at-home sample collection kit for use with multiple authorized diagnostic tests.

The orally administered antiviral agent will enter phase II trials to be conducted at multiple US locations, including 3 Mayo Clinic sites.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

A blog post on COVID-19 transmission by a US biology professor at UMass Dartmouth went viral this week. Find out what your patients are reading and test yourself, too.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

New research suggests children and young adults are at greater risk for severe complications from COVID-19 than previously thought.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

What types of products do American CBD users prefer? Are they upping their CBD use due to COVID-19? Answers to these questions and more from a recent survey of US adults.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

The 2 new guidance documents provide sponsors with clear direction on data required for IND application and on the structure of phase 2 and 3 clinical trials.

NIH Tuesday released updates to its COVID-19 treatment guidelines including guidance on antithrombotic treatment and remdesivir clinical trial results.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

How many cases of COVID-19 have been confirmed globally and nationally? How many recoveries? Get your daily COVID-19 update here.

Poorly controlled blood glucose in patients with diabetes hospitalized for COVID-19 significantly reduces odds of survival.

The FDA issued the first EUA for a new category of tests to be used in the ongoing COVID-19 pandemic.

How many cases of COVID-19 have been confirmed globally and nationally? How many recoveries? Get your daily COVID-19 update here.

A NIH clinical trial begins today that will compare antiviral remdesivir alone to remdesivir plus anti-inflammatory baricitinib in patients critically ill with COVID-19.

Authors of a new study found no association between treatment with high blood pressure drugs and an increased risk of contracting novel COVID-19.